![](/img/cover-not-exists.png)
Multicentric neoadjuvant pilot Phase II study of cetuximab combined with docetaxel in operable triple negative breast cancer
Nabholtz, J.M., Chalabi, N., Radosevic-Robin, N., Dauplat, M.M., Mouret-Reynier, M.A., Van Praagh, I., Servent, V., Jacquin, JP, Benmammar, K.E., Kullab, S., Bahadoor, M.R.K., Kwiatkowski, F., Cayre,Volume:
138
Language:
english
Journal:
International Journal of Cancer
DOI:
10.1002/ijc.29952
Date:
May, 2016
File:
PDF, 233 KB
english, 2016